Bioinformatics service
The Core Facility provides free experimental design consultation. Based on the user’s needs, we provide different levels of bioinformatics analysis, i.e. preprocessing of data, normalization, statistical analysis, annotation, gene ontology, and pathway analysis, in collaboration with the Bioinformatics Core Facility.
Primary and secondary analysis is performed using the Illumina DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT Platform at the Genomics Core Facility. This platform provides accurate, ultra-rapid primary and secondary genomic analysis of sequencing data. Multiple workflows are available.
Illumina DRAGEN Bio-IT Platform v3.9
DNA Pipeline (SNV/Indel, Copy Number Variants, Structural Variants, Repeat expansion, Ploidy, and more)
RNA Pipeline (Gene expression, Gene fusions, Variant calling, Single Cell)
Methylation Pipeline
Amplicon Pipeline
Pricing will include a license fee per Gb of data processed and personnel costs per hour. Contact us for more information.
The Genomics Core Facility has a close collaboration with the University of Oslo/Oslo University Hospital Bioinformatics core facility, which can assist in higher-level analysis.
News
Jan 4, 2023
The Genomics and Bioinformatics Core Facilities resumes the drop-in hour every Wednesday between 2:30-3:30 PM. Follow the Zoom link below.
[More]
Oct 25, 2022
The Oslo University Hospital and University of Oslo Genomics Core Facility in collaboration with 10x Genomics will launch the new multiomics platform established in Norway.
[More]
Contact Information:
Genomics@rr-research.no
Unit Leader Core Facility
Susanne Lorenz, PhD
Susanne.Lorenz@rr-research.no
Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.
Leonardo.A.Meza-Zepeda@rr-research.no
Follow us via Twitter
Visiting address:
Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building
Norwegian Radium Hospital
Ullernchaussen 66, Lamell 3, 2B
NO-0379 Oslo, NORWAY
+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office
................................................................
